552 related articles for article (PubMed ID: 16647824)
1. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
2. Melatonin as a selective estrogen enzyme modulator.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Curr Cancer Drug Targets; 2008 Dec; 8(8):691-702. PubMed ID: 19075592
[TBL] [Abstract][Full Text] [Related]
3. Melatonin-estrogen interactions in breast cancer.
Sánchez-Barceló EJ; Cos S; Mediavilla D; Martínez-Campa C; González A; Alonso-González C
J Pineal Res; 2005 May; 38(4):217-22. PubMed ID: 15813897
[TBL] [Abstract][Full Text] [Related]
4. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
[TBL] [Abstract][Full Text] [Related]
5. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and mammary pathological growth.
Cos S; Sánchez-Barceló EJ
Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
[TBL] [Abstract][Full Text] [Related]
7. [Dual effects of androgens on mammary gland].
Brettes JP; Mathelin C
Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
9. Melatonin, environmental light, and breast cancer.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Esquifino AI; Cardinali DP; Maestroni GJ
Breast Cancer Res Treat; 2008 Apr; 108(3):339-50. PubMed ID: 17541739
[TBL] [Abstract][Full Text] [Related]
10. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium.
Martínez-Campa C; Alonso-González C; Mediavilla MD; Cos S; González A; Ramos S; Sánchez-Barceló EJ
J Pineal Res; 2006 May; 40(4):291-6. PubMed ID: 16635015
[TBL] [Abstract][Full Text] [Related]
11. Melatonin and mammary cancer: a short review.
Sánchez-Barceló EJ; Cos S; Fernández R; Mediavilla MD
Endocr Relat Cancer; 2003 Jun; 10(2):153-9. PubMed ID: 12790777
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitor-induced joint pain: melatonin's role.
Burk R
Med Hypotheses; 2008 Dec; 71(6):862-7. PubMed ID: 18782656
[TBL] [Abstract][Full Text] [Related]
13. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
Blask DE; Dauchy RT; Brainard GC; Hanifin JP
Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
[TBL] [Abstract][Full Text] [Related]
14. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.
Hill SM; Blask DE
Cancer Res; 1988 Nov; 48(21):6121-6. PubMed ID: 3167858
[TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.
Cos S; González A; Güezmes A; Mediavilla MD; Martínez-Campa C; Alonso-González C; Sánchez-Barceló EJ
Int J Cancer; 2006 Jan; 118(2):274-8. PubMed ID: 16080194
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.
Cucina A; Proietti S; D'Anselmi F; Coluccia P; Dinicola S; Frati L; Bizzarri M
J Pineal Res; 2009 Mar; 46(2):172-80. PubMed ID: 19175854
[TBL] [Abstract][Full Text] [Related]
17. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects.
Cini G; Neri B; Pacini A; Cesati V; Sassoli C; Quattrone S; D'Apolito M; Fazio A; Scapagnini G; Provenzani A; Quattrone A
J Pineal Res; 2005 Aug; 39(1):12-20. PubMed ID: 15978052
[TBL] [Abstract][Full Text] [Related]
19. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
